Chronix Biomedical

Chronix Biomedical is pioneering a groundbreaking approach to diagnosing and managing chronic diseases and cancer. It has developed proprietary technology to measure and classify circulating nucleic acids, DNA sequences found in the blood that are associated with specific changes related to diseases and health conditions. Chronix plans to collaborate with various partners to develop and promote its DNA-based tests, which have the potential to transform the management of various cancers and other diseases. Chronix is headquartered in California and has a research facility in Germany.